Clinical Trial Update: Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating interferon gamma-primed mesenchymal stromal cells for moderate-to-severe persistent asthma has been terminated; the update summarizes t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Interferon gamma-primed mesenchymal stromal cells (Interferon gamma-primed mesenchymal stromal cells)

Snippet

Sponsor: Emory University | Conditions: Asthma | Phase 1 | Status: TERMINATED